Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joep J de Jong

Showing results (1-10 of 49) with videos related to

Pageof 5
Sort By:
JAMA Neurology|March 16, 2026
Humble by ExperienceJoep J de Jong
European Urology|January 17, 2022
Re: Gottfrid Sjödahl, Johan Abrahamsson, Karin Holmsten, et al. Different Responses to Neoadjuvant Chemotherapy in Urothelial Carcinoma Molecular Subtypes. Eur Urol. 2022;81:316-7.: Neoadjuvant Chemotherapy Response in Muscle-invasive Bladder Cancer: Differences in Intrinsic Biology or Subtyping Nomenclature?Joep J de Jong, Ewan A Gibb
Nature Reviews. Urology|December 5, 2019
Molecular and clinical heterogeneity within the luminal subtypeJoep J de Jong, Ellen C Zwarthoff
European Urology|August 12, 2024
Re: EAU Guidelines on Muscle-invasive and Metastatic Bladder CancerJoep J de Jong, Yair Lotan, Joost L Boormans
European Urology Oncology|June 10, 2025
Long Noncoding RNAs Identify a Subgroup of Patients with Low-grade Non-muscle-invasive Bladder Cancer with Less Favorable OutcomesJoep J de Jong, Peter C Black, Lars Dyrskjøt, et al.
Expert Review of Molecular Diagnostics|December 10, 2025
Unlocking the potential of long non-coding RNAs in bladder cancerYoran L Tomassen, Ewan A Gibb, Yair Lotan, et al.
Bladder Cancer (Amsterdam, Netherlands)|November 13, 2018
Hyperthermic Intravesical Chemotherapy for BCG Unresponsive Non-Muscle Invasive Bladder Cancer PatientsJoep J de Jong, Kees Hendricksen, Marloes Rosier, et al.
Current Urology Reports|May 16, 2020
Correction to: Genomic Subtyping in Bladder CancerTuomas Jalanko, Joep J de Jong, Ewan A Gibb, et al.
Current Urology Reports|March 14, 2020
Genomic Subtyping in Bladder CancerTuomas Jalanko, Joep J de Jong, Ewan A Gibb, et al.
Current Opinion in Urology|August 2, 2022
RNA-based urinary assays for non-muscle invasive bladder cancerOlga M Pijpers, Joep J de Jong, Tahlita C M Zuiverloon, et al.
Pageof 5

Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
JAMA Neurology|March 16, 2026
Humble by ExperienceJoep J de Jong
European Urology|January 17, 2022
Re: Gottfrid Sjödahl, Johan Abrahamsson, Karin Holmsten, et al. Different Responses to Neoadjuvant Chemotherapy in Urothelial Carcinoma Molecular Subtypes. Eur Urol. 2022;81:316-7.: Neoadjuvant Chemotherapy Response in Muscle-invasive Bladder Cancer: Differences in Intrinsic Biology or Subtyping Nomenclature?Joep J de Jong, Ewan A Gibb
Nature Reviews. Urology|December 5, 2019
Molecular and clinical heterogeneity within the luminal subtypeJoep J de Jong, Ellen C Zwarthoff
European Urology|August 12, 2024
Re: EAU Guidelines on Muscle-invasive and Metastatic Bladder CancerJoep J de Jong, Yair Lotan, Joost L Boormans
European Urology Oncology|June 10, 2025
Long Noncoding RNAs Identify a Subgroup of Patients with Low-grade Non-muscle-invasive Bladder Cancer with Less Favorable OutcomesJoep J de Jong, Peter C Black, Lars Dyrskjøt, et al.
Expert Review of Molecular Diagnostics|December 10, 2025
Unlocking the potential of long non-coding RNAs in bladder cancerYoran L Tomassen, Ewan A Gibb, Yair Lotan, et al.
Bladder Cancer (Amsterdam, Netherlands)|November 13, 2018
Hyperthermic Intravesical Chemotherapy for BCG Unresponsive Non-Muscle Invasive Bladder Cancer PatientsJoep J de Jong, Kees Hendricksen, Marloes Rosier, et al.
Current Urology Reports|May 16, 2020
Correction to: Genomic Subtyping in Bladder CancerTuomas Jalanko, Joep J de Jong, Ewan A Gibb, et al.
Current Urology Reports|March 14, 2020
Genomic Subtyping in Bladder CancerTuomas Jalanko, Joep J de Jong, Ewan A Gibb, et al.
Current Opinion in Urology|August 2, 2022
RNA-based urinary assays for non-muscle invasive bladder cancerOlga M Pijpers, Joep J de Jong, Tahlita C M Zuiverloon, et al.
Pageof 5